{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-017438","form_type":"8-K","ticker":"TBPH","cik":"0001583107","company_name":"Theravance Biopharma, Inc.","filed_at":"2025-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.075177+00:00","generated_at":"2026-05-26T03:36:00.044459+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Theravance Biopharma reports record Q4 and full year 2024 financial results with YUPELRI and TRELEGY milestones","bullets":["YUPELRI US net sales reached $66.7M in Q4 2024 and $238.6M for full year, up 10% and 8% year-over-year, driven by increased customer demand.","TRELEGY global net sales of $3.46B in FY 2024 triggered a $50M milestone from Royalty Pharma, received in February 2025.","Company ended Q4 2024 with $88M cash, and CYPRESS study on track to enroll final patient by mid-2025.","Q4 2024 total revenue was $18.8M from Viatris collaboration, with net loss of $15.5M and non-GAAP net loss of $2.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-017438","json":"https://secwatch.observer/filing/0001104659-25-017438.json","markdown":"https://secwatch.observer/filing/0001104659-25-017438.md","text":"https://secwatch.observer/filing/0001104659-25-017438.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583107/000110465925017438/0001104659-25-017438-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583107/000110465925017438/tm257513d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-26T03:36:00.044459+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}